Point of Care STI Testing

Recruiting now · Not applicable

Conditions studied: Point of Care STI Testing

In brief

The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.

Key facts

Study ID

NCT06844045

Run by

Icahn School of Medicine at Mount Sinai

People needed

6460

Starts

2026-02-24

Expected to finish

2026-12-31

Last updated by the study team

2026-05-05

Who can join

Age: 16 and older, up to 24. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients age 16-24 years receiving POCT or lab-based GC/CT testing

You may not qualify if…

• Patients with known HIV or active PrEP prescriptions.

Where it is running

• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.